GATA1 IS OVEREXPRESSED IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND IT IS NORMALIZED BY ANAGRELIDE TREATMENT.

被引：0
|
作者：
Rinaldi, C. [1 ]
Graham, C. [1 ]
Brown, L. [1 ]
机构：
[1] Lincoln Univ, Lincoln, England
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P392
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Response predictive factors to anagrelide in essential thrombocythemia diagnosed patients
    Besses, Carlos
    Giralt, Manuel
    Hernandez-Nieto, Luis
    Burgaleta, Carmen
    Navas, Victor
    Ramirez, Gema
    Vicente, Vicente
    Carbonell, Felix
    BLOOD, 2007, 110 (11) : 236B - 236B
  • [22] Long-term use of anagrelide in the treatment of children with essential thrombocythemia
    Lackner, Herwig
    Urban, Christian
    Benesch, Martin
    Moser, Andrea
    Sovinz, Petra
    Schwinger, Wolfgang
    Dornbusch, Hans Juergen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (04) : 358 - 359
  • [23] Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists
    Reilly, John T.
    HEMATOLOGY, 2009, 14 (01) : 1 - 10
  • [24] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
    Hultdin, Magnus
    Sundstrom, Gunnel
    Wahlin, Anders
    Lundstrom, Berith
    Birgegard, Gunnar
    Engstrom-Laurent, Anna
    MEDICAL ONCOLOGY, 2007, 24 (01) : 63 - 70
  • [25] Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
    Magnus Hultdin
    Gunnel Sundström
    Anders Wahlin
    Berith Lundström
    Jan Samuelsson
    Gunnar Birgegård
    Anna Engström-Laurent
    Medical Oncology, 2007, 24 : 63 - 70
  • [26] Long-term use of anagrelide in young patients with essential thrombocythemia
    Storen, EC
    Tefferi, A
    BLOOD, 2001, 97 (04) : 863 - 866
  • [27] GATA1 is over-expressed in essential thrombocytemia
    Rinaldi, Ciro R.
    Li, Donglan
    Ciancia, Rosanna
    Picardi, Marco
    Rinaldi, Paola
    Martinelli, Vincenzo
    Nucifora, Giuseppina
    Pape, Fabrizio
    Rotoli, Bruno
    BLOOD, 2007, 110 (11) : 458A - 459A
  • [28] ADHERENCE SUPPORT PROGRAM FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET) TREATED WITH ANAGRELIDE
    Ramirez, G.
    Cardenes, J.
    Rejas, R.
    Plaza, S.
    Garcia-Ort, L.
    Navas, V.
    HAEMATOLOGICA, 2014, 99 : 669 - 669
  • [29] THERAPY WITH ANAGRELIDE IN PATIENTS AFFECTED BY ESSENTIAL THROMBOCYTHEMIA - PRELIMINARY-RESULTS
    MAZZUCCONI, MG
    DESANCTIS, V
    CHISTOLINI, A
    DRAGONI, F
    MANDELLI, F
    HAEMATOLOGICA, 1992, 77 (04) : 315 - 317
  • [30] EFFECT OF ANAGRELIDE ON PLATELET, COAGULANT AND ENDOTHELIAL FUNCTION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Cacciola, R. R.
    Di Francesco, E.
    Pezzella, F.
    Tibullo, D.
    Cacciola, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 584 - 584
12345